Synthetic Genomics Inc. and a unit of United Therapeutics Corp have announced they are teaming up to develop pig lungs that have been genetically altered to be compatible with humans. If successful, the feat could help address the shortage of transplant organs.
Available to comment on the scientific aspects of the effort is Scripps Research Institute Professor Daniel R. Salomon, M.D., who is president of the American Society of Transplantation. Dr. Salomon was involved in the first round of genetically engineered pigs for human transplantation, including consulting for Imutran and Biotransplant.
"I have no doubt that Dr. Venter and colleagues can develop a very fine genetic map of the pig," Dr. Salomon says. "But genetically engineering this into a human-compatible organ is a huge leap."
More information on Dr. Salomon is available at:
-His faculty web page, http://www.scripps.edu/research/faculty/salomon
-The profile, "Dan Salomon Embraces the Complexity of Transplant Medicine," http://www.scripps.edu/newsandviews/e_20130603/salomon.html
-His laboratory web page, http://www.scripps.edu/salomon/Salomon_Lab/Home.html